nodes	percent_of_prediction	percent_of_DWPC	metapath
Modafinil—CYP1A2—chronic obstructive pulmonary disease	0.399	1	CbGaD
Modafinil—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0477	0.129	CbGbCtD
Modafinil—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0477	0.129	CbGbCtD
Modafinil—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0397	0.107	CbGbCtD
Modafinil—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0397	0.107	CbGbCtD
Modafinil—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0374	0.101	CbGbCtD
Modafinil—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0304	0.0822	CbGbCtD
Modafinil—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0301	0.0812	CbGbCtD
Modafinil—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0206	0.0555	CbGbCtD
Modafinil—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.02	0.0541	CbGbCtD
Modafinil—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0196	0.053	CbGbCtD
Modafinil—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0175	0.0472	CbGbCtD
Modafinil—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0103	0.0277	CbGbCtD
Modafinil—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00969	0.0262	CbGbCtD
Modafinil—Levomethadyl Acetate—CHRNA3—chronic obstructive pulmonary disease	0.000734	0.192	CrCbGaD
Modafinil—Ketoprofen—CXCL8—chronic obstructive pulmonary disease	0.000383	0.1	CrCbGaD
Modafinil—Warfarin—CYP1A1—chronic obstructive pulmonary disease	0.000232	0.0605	CrCbGaD
Modafinil—Warfarin—CYP1A2—chronic obstructive pulmonary disease	0.000224	0.0583	CrCbGaD
Modafinil—Fosphenytoin—ALB—chronic obstructive pulmonary disease	0.000212	0.0554	CrCbGaD
Modafinil—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00019	0.00103	CcSEcCtD
Modafinil—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.000189	0.00103	CcSEcCtD
Modafinil—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000188	0.00102	CcSEcCtD
Modafinil—Infection—Formoterol—chronic obstructive pulmonary disease	0.000188	0.00102	CcSEcCtD
Modafinil—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000187	0.00101	CcSEcCtD
Modafinil—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000187	0.00101	CcSEcCtD
Modafinil—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000187	0.00101	CcSEcCtD
Modafinil—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000187	0.00101	CcSEcCtD
Modafinil—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000186	0.00101	CcSEcCtD
Modafinil—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000186	0.00101	CcSEcCtD
Modafinil—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000186	0.00101	CcSEcCtD
Modafinil—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000186	0.00101	CcSEcCtD
Modafinil—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000186	0.00101	CcSEcCtD
Modafinil—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000186	0.00101	CcSEcCtD
Modafinil—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000185	0.001	CcSEcCtD
Modafinil—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000185	0.001	CcSEcCtD
Modafinil—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000185	0.001	CcSEcCtD
Modafinil—Infection—Montelukast—chronic obstructive pulmonary disease	0.000185	0.001	CcSEcCtD
Modafinil—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000184	0.001	CcSEcCtD
Modafinil—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000184	0.000999	CcSEcCtD
Modafinil—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000184	0.000999	CcSEcCtD
Modafinil—Cinnarizine—CYP1A1—chronic obstructive pulmonary disease	0.000184	0.048	CrCbGaD
Modafinil—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000184	0.000996	CcSEcCtD
Modafinil—Phenoxybenzamine—ADRB2—chronic obstructive pulmonary disease	0.000184	0.0479	CrCbGaD
Modafinil—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000183	0.000991	CcSEcCtD
Modafinil—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000183	0.00099	CcSEcCtD
Modafinil—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000182	0.000988	CcSEcCtD
Modafinil—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000181	0.000979	CcSEcCtD
Modafinil—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000179	0.000972	CcSEcCtD
Modafinil—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000179	0.000972	CcSEcCtD
Modafinil—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000178	0.000965	CcSEcCtD
Modafinil—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000177	0.000962	CcSEcCtD
Modafinil—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000177	0.000962	CcSEcCtD
Modafinil—Cinnarizine—CYP1A2—chronic obstructive pulmonary disease	0.000177	0.0462	CrCbGaD
Modafinil—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000176	0.000957	CcSEcCtD
Modafinil—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000176	0.000956	CcSEcCtD
Modafinil—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000176	0.000953	CcSEcCtD
Modafinil—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000175	0.000948	CcSEcCtD
Modafinil—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000174	0.000944	CcSEcCtD
Modafinil—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000173	0.000939	CcSEcCtD
Modafinil—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000173	0.000939	CcSEcCtD
Modafinil—Atomoxetine—SLC6A4—chronic obstructive pulmonary disease	0.000173	0.0451	CrCbGaD
Modafinil—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000173	0.000937	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000173	0.000937	CcSEcCtD
Modafinil—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000172	0.000931	CcSEcCtD
Modafinil—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000172	0.000931	CcSEcCtD
Modafinil—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000171	0.000926	CcSEcCtD
Modafinil—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000171	0.000925	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000169	0.000918	CcSEcCtD
Modafinil—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000169	0.000917	CcSEcCtD
Modafinil—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000169	0.000917	CcSEcCtD
Modafinil—Fenoprofen—ALB—chronic obstructive pulmonary disease	0.000169	0.0441	CrCbGaD
Modafinil—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000169	0.000915	CcSEcCtD
Modafinil—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000169	0.000915	CcSEcCtD
Modafinil—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000168	0.000912	CcSEcCtD
Modafinil—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000167	0.000908	CcSEcCtD
Modafinil—Carbamazepine—CYP1A2—chronic obstructive pulmonary disease	0.000167	0.0436	CrCbGaD
Modafinil—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000167	0.000906	CcSEcCtD
Modafinil—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000167	0.000906	CcSEcCtD
Modafinil—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000167	0.000905	CcSEcCtD
Modafinil—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000166	0.000902	CcSEcCtD
Modafinil—Injury—Prednisone—chronic obstructive pulmonary disease	0.000165	0.000896	CcSEcCtD
Modafinil—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000165	0.000896	CcSEcCtD
Modafinil—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000165	0.000894	CcSEcCtD
Modafinil—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000164	0.000892	CcSEcCtD
Modafinil—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000164	0.000888	CcSEcCtD
Modafinil—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000164	0.000888	CcSEcCtD
Modafinil—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000164	0.000887	CcSEcCtD
Modafinil—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000164	0.000887	CcSEcCtD
Modafinil—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000164	0.000887	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000163	0.000885	CcSEcCtD
Modafinil—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000162	0.00088	CcSEcCtD
Modafinil—Pain—Formoterol—chronic obstructive pulmonary disease	0.000162	0.00088	CcSEcCtD
Modafinil—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000162	0.00088	CcSEcCtD
Modafinil—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000162	0.00088	CcSEcCtD
Modafinil—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000162	0.000879	CcSEcCtD
Modafinil—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000162	0.000877	CcSEcCtD
Modafinil—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000162	0.000877	CcSEcCtD
Modafinil—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000161	0.000872	CcSEcCtD
Modafinil—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00016	0.00087	CcSEcCtD
Modafinil—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00016	0.000869	CcSEcCtD
Modafinil—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00016	0.000866	CcSEcCtD
Modafinil—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000159	0.000864	CcSEcCtD
Modafinil—Pain—Montelukast—chronic obstructive pulmonary disease	0.000159	0.000862	CcSEcCtD
Modafinil—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000159	0.00086	CcSEcCtD
Modafinil—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000158	0.000855	CcSEcCtD
Modafinil—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000157	0.000852	CcSEcCtD
Modafinil—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000157	0.000852	CcSEcCtD
Modafinil—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000157	0.000849	CcSEcCtD
Modafinil—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000156	0.000848	CcSEcCtD
Modafinil—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000156	0.000848	CcSEcCtD
Modafinil—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000156	0.000847	CcSEcCtD
Modafinil—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000156	0.000845	CcSEcCtD
Modafinil—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000155	0.000843	CcSEcCtD
Modafinil—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000155	0.000841	CcSEcCtD
Modafinil—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000155	0.000841	CcSEcCtD
Modafinil—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000155	0.000839	CcSEcCtD
Modafinil—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000154	0.000838	CcSEcCtD
Modafinil—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000153	0.000831	CcSEcCtD
Modafinil—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000153	0.000831	CcSEcCtD
Modafinil—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000152	0.000824	CcSEcCtD
Modafinil—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000152	0.000824	CcSEcCtD
Modafinil—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000151	0.000817	CcSEcCtD
Modafinil—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000151	0.000817	CcSEcCtD
Modafinil—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00015	0.000813	CcSEcCtD
Modafinil—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00015	0.000813	CcSEcCtD
Modafinil—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00015	0.000813	CcSEcCtD
Modafinil—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00015	0.000813	CcSEcCtD
Modafinil—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.00015	0.000811	CcSEcCtD
Modafinil—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000149	0.000811	CcSEcCtD
Modafinil—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000148	0.000805	CcSEcCtD
Modafinil—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000148	0.000804	CcSEcCtD
Modafinil—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000148	0.000803	CcSEcCtD
Modafinil—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000148	0.000803	CcSEcCtD
Modafinil—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000148	0.000801	CcSEcCtD
Modafinil—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000148	0.000801	CcSEcCtD
Modafinil—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000147	0.000799	CcSEcCtD
Modafinil—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000147	0.000799	CcSEcCtD
Modafinil—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000147	0.000797	CcSEcCtD
Modafinil—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000147	0.000797	CcSEcCtD
Modafinil—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000146	0.000795	CcSEcCtD
Modafinil—Phenprocoumon—ALB—chronic obstructive pulmonary disease	0.000146	0.038	CrCbGaD
Modafinil—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000145	0.000786	CcSEcCtD
Modafinil—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000144	0.000783	CcSEcCtD
Modafinil—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000144	0.000781	CcSEcCtD
Modafinil—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000142	0.000772	CcSEcCtD
Modafinil—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000142	0.000768	CcSEcCtD
Modafinil—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000142	0.000768	CcSEcCtD
Modafinil—Oxcarbazepine—ALB—chronic obstructive pulmonary disease	0.000142	0.037	CrCbGaD
Modafinil—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00014	0.000758	CcSEcCtD
Modafinil—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00014	0.000758	CcSEcCtD
Modafinil—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00014	0.000757	CcSEcCtD
Modafinil—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000139	0.000756	CcSEcCtD
Modafinil—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000139	0.000755	CcSEcCtD
Modafinil—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000137	0.000743	CcSEcCtD
Modafinil—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000136	0.000738	CcSEcCtD
Modafinil—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000136	0.000738	CcSEcCtD
Modafinil—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000134	0.000728	CcSEcCtD
Modafinil—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000134	0.000728	CcSEcCtD
Modafinil—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000134	0.000727	CcSEcCtD
Modafinil—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000133	0.000723	CcSEcCtD
Modafinil—Atomoxetine—HTR2A—chronic obstructive pulmonary disease	0.000133	0.0347	CrCbGaD
Modafinil—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000132	0.000716	CcSEcCtD
Modafinil—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000131	0.000713	CcSEcCtD
Modafinil—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00013	0.000704	CcSEcCtD
Modafinil—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00013	0.000704	CcSEcCtD
Modafinil—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000129	0.000701	CcSEcCtD
Modafinil—Warfarin—ALB—chronic obstructive pulmonary disease	0.000129	0.0337	CrCbGaD
Modafinil—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000129	0.000697	CcSEcCtD
Modafinil—Diphenhydramine—CYP1A2—chronic obstructive pulmonary disease	0.000127	0.0332	CrCbGaD
Modafinil—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000127	0.00069	CcSEcCtD
Modafinil—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000127	0.000687	CcSEcCtD
Modafinil—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000125	0.00068	CcSEcCtD
Modafinil—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000125	0.00068	CcSEcCtD
Modafinil—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000123	0.000666	CcSEcCtD
Modafinil—Methadone—CYP1A2—chronic obstructive pulmonary disease	0.000123	0.0321	CrCbGaD
Modafinil—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000123	0.000665	CcSEcCtD
Modafinil—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000656	CcSEcCtD
Modafinil—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000121	0.000654	CcSEcCtD
Modafinil—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000121	0.000654	CcSEcCtD
Modafinil—Rash—Formoterol—chronic obstructive pulmonary disease	0.00012	0.000649	CcSEcCtD
Modafinil—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00012	0.000649	CcSEcCtD
Modafinil—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00012	0.000648	CcSEcCtD
Modafinil—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00012	0.000648	CcSEcCtD
Modafinil—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000119	0.000648	CcSEcCtD
Modafinil—Headache—Formoterol—chronic obstructive pulmonary disease	0.000119	0.000645	CcSEcCtD
Modafinil—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000119	0.000645	CcSEcCtD
Modafinil—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000119	0.000644	CcSEcCtD
Modafinil—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000118	0.000643	CcSEcCtD
Modafinil—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000118	0.000642	CcSEcCtD
Modafinil—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000118	0.000641	CcSEcCtD
Modafinil—Rash—Montelukast—chronic obstructive pulmonary disease	0.000117	0.000635	CcSEcCtD
Modafinil—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000117	0.000635	CcSEcCtD
Modafinil—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000117	0.000634	CcSEcCtD
Modafinil—Depression—Prednisone—chronic obstructive pulmonary disease	0.000117	0.000633	CcSEcCtD
Modafinil—Headache—Montelukast—chronic obstructive pulmonary disease	0.000116	0.000631	CcSEcCtD
Modafinil—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000115	0.000624	CcSEcCtD
Modafinil—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000114	0.000618	CcSEcCtD
Modafinil—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000114	0.000616	CcSEcCtD
Modafinil—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000113	0.000613	CcSEcCtD
Modafinil—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000113	0.000613	CcSEcCtD
Modafinil—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000113	0.000612	CcSEcCtD
Modafinil—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000113	0.000612	CcSEcCtD
Modafinil—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000113	0.000611	CcSEcCtD
Modafinil—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000113	0.000611	CcSEcCtD
Modafinil—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000112	0.000609	CcSEcCtD
Modafinil—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000111	0.0006	CcSEcCtD
Modafinil—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00011	0.000599	CcSEcCtD
Modafinil—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000109	0.000592	CcSEcCtD
Modafinil—SLC6A3—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.000109	0.00256	CbGpPWpGaD
Modafinil—ADRA1B—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.000109	0.00255	CbGpPWpGaD
Modafinil—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000109	0.00059	CcSEcCtD
Modafinil—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000107	0.00252	CbGpPWpGaD
Modafinil—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000107	0.00058	CcSEcCtD
Modafinil—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000106	0.000577	CcSEcCtD
Modafinil—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000106	0.000574	CcSEcCtD
Modafinil—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000106	0.00249	CbGpPWpGaD
Modafinil—ADRA1B—Calcium Regulation in the Cardiac Cell—ADRB2—chronic obstructive pulmonary disease	0.000106	0.00248	CbGpPWpGaD
Modafinil—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000105	0.000567	CcSEcCtD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000103	0.00243	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	0.000103	0.00243	CbGpPWpGaD
Modafinil—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000103	0.00243	CbGpPWpGaD
Modafinil—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000103	0.00056	CcSEcCtD
Modafinil—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000103	0.000557	CcSEcCtD
Modafinil—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000103	0.000557	CcSEcCtD
Modafinil—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	0.000102	0.00239	CbGpPWpGaD
Modafinil—CYP2B6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000101	0.00238	CbGpPWpGaD
Modafinil—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000101	0.000548	CcSEcCtD
Modafinil—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	0.000101	0.00236	CbGpPWpGaD
Modafinil—ADRA1B—LPA receptor mediated events—CXCL8—chronic obstructive pulmonary disease	0.0001	0.00236	CbGpPWpGaD
Modafinil—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.0001	0.000544	CcSEcCtD
Modafinil—CYP2B6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.0001	0.00235	CbGpPWpGaD
Modafinil—Ketoprofen—ALB—chronic obstructive pulmonary disease	9.96e-05	0.026	CrCbGaD
Modafinil—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	9.93e-05	0.000539	CcSEcCtD
Modafinil—CYP3A5—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	9.89e-05	0.00232	CbGpPWpGaD
Modafinil—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	9.78e-05	0.0023	CbGpPWpGaD
Modafinil—CYP3A5—Biological oxidations—GCLC—chronic obstructive pulmonary disease	9.78e-05	0.0023	CbGpPWpGaD
Modafinil—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	9.67e-05	0.00227	CbGpPWpGaD
Modafinil—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	9.65e-05	0.00227	CbGpPWpGaD
Modafinil—Angiopathy—Prednisone—chronic obstructive pulmonary disease	9.54e-05	0.000517	CcSEcCtD
Modafinil—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	9.49e-05	0.000515	CcSEcCtD
Modafinil—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	9.39e-05	0.000509	CcSEcCtD
Modafinil—Phenytoin—ALB—chronic obstructive pulmonary disease	9.38e-05	0.0245	CrCbGaD
Modafinil—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	9.32e-05	0.00219	CbGpPWpGaD
Modafinil—Insomnia—Prednisolone—chronic obstructive pulmonary disease	9.29e-05	0.000504	CcSEcCtD
Modafinil—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	9.23e-05	0.0005	CcSEcCtD
Modafinil—Mental disorder—Prednisone—chronic obstructive pulmonary disease	9.21e-05	0.000499	CcSEcCtD
Modafinil—Malnutrition—Prednisone—chronic obstructive pulmonary disease	9.15e-05	0.000496	CcSEcCtD
Modafinil—ADRA1B—LPA receptor mediated events—MMP9—chronic obstructive pulmonary disease	9.09e-05	0.00213	CbGpPWpGaD
Modafinil—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	9.08e-05	0.00213	CbGpPWpGaD
Modafinil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	8.88e-05	0.00208	CbGpPWpGaD
Modafinil—Pain—Prednisolone—chronic obstructive pulmonary disease	8.79e-05	0.000477	CcSEcCtD
Modafinil—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	8.76e-05	0.00206	CbGpPWpGaD
Modafinil—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	8.7e-05	0.00204	CbGpPWpGaD
Modafinil—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	8.49e-05	0.00046	CcSEcCtD
Modafinil—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	8.47e-05	0.000459	CcSEcCtD
Modafinil—Anaemia—Prednisone—chronic obstructive pulmonary disease	8.46e-05	0.000459	CcSEcCtD
Modafinil—CYP2B6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	8.41e-05	0.00198	CbGpPWpGaD
Modafinil—Agitation—Prednisone—chronic obstructive pulmonary disease	8.41e-05	0.000456	CcSEcCtD
Modafinil—Angioedema—Prednisone—chronic obstructive pulmonary disease	8.36e-05	0.000453	CcSEcCtD
Modafinil—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	8.36e-05	0.00196	CbGpPWpGaD
Modafinil—CYP2B6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	8.3e-05	0.00195	CbGpPWpGaD
Modafinil—Malaise—Prednisone—chronic obstructive pulmonary disease	8.25e-05	0.000447	CcSEcCtD
Modafinil—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	8.25e-05	0.00194	CbGpPWpGaD
Modafinil—CYP3A5—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	8.22e-05	0.00193	CbGpPWpGaD
Modafinil—Vertigo—Prednisone—chronic obstructive pulmonary disease	8.22e-05	0.000446	CcSEcCtD
Modafinil—Syncope—Prednisone—chronic obstructive pulmonary disease	8.2e-05	0.000445	CcSEcCtD
Modafinil—Urticaria—Prednisolone—chronic obstructive pulmonary disease	8.16e-05	0.000443	CcSEcCtD
Modafinil—CYP3A5—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	8.11e-05	0.0019	CbGpPWpGaD
Modafinil—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	8.04e-05	0.000436	CcSEcCtD
Modafinil—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	7.98e-05	0.00187	CbGpPWpGaD
Modafinil—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	7.93e-05	0.00186	CbGpPWpGaD
Modafinil—Convulsion—Prednisone—chronic obstructive pulmonary disease	7.93e-05	0.00043	CcSEcCtD
Modafinil—Hypertension—Prednisone—chronic obstructive pulmonary disease	7.9e-05	0.000428	CcSEcCtD
Modafinil—ADRA1B—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	7.88e-05	0.00185	CbGpPWpGaD
Modafinil—Myalgia—Prednisone—chronic obstructive pulmonary disease	7.79e-05	0.000422	CcSEcCtD
Modafinil—Arthralgia—Prednisone—chronic obstructive pulmonary disease	7.79e-05	0.000422	CcSEcCtD
Modafinil—Anxiety—Prednisone—chronic obstructive pulmonary disease	7.76e-05	0.000421	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	7.74e-05	0.00042	CcSEcCtD
Modafinil—Discomfort—Prednisone—chronic obstructive pulmonary disease	7.7e-05	0.000417	CcSEcCtD
Modafinil—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.65e-05	0.0018	CbGpPWpGaD
Modafinil—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	7.57e-05	0.000411	CcSEcCtD
Modafinil—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.56e-05	0.00178	CbGpPWpGaD
Modafinil—Oedema—Prednisone—chronic obstructive pulmonary disease	7.47e-05	0.000405	CcSEcCtD
Modafinil—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	7.47e-05	0.000405	CcSEcCtD
Modafinil—Infection—Prednisone—chronic obstructive pulmonary disease	7.42e-05	0.000402	CcSEcCtD
Modafinil—Shock—Prednisone—chronic obstructive pulmonary disease	7.35e-05	0.000398	CcSEcCtD
Modafinil—ADRA1B—LPA receptor mediated events—EGFR—chronic obstructive pulmonary disease	7.34e-05	0.00172	CbGpPWpGaD
Modafinil—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	7.32e-05	0.000397	CcSEcCtD
Modafinil—Tachycardia—Prednisone—chronic obstructive pulmonary disease	7.29e-05	0.000395	CcSEcCtD
Modafinil—Skin disorder—Prednisone—chronic obstructive pulmonary disease	7.25e-05	0.000393	CcSEcCtD
Modafinil—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	7.22e-05	0.000391	CcSEcCtD
Modafinil—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	7.2e-05	0.00169	CbGpPWpGaD
Modafinil—Anorexia—Prednisone—chronic obstructive pulmonary disease	7.12e-05	0.000386	CcSEcCtD
Modafinil—ADRA1B—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	7.09e-05	0.00167	CbGpPWpGaD
Modafinil—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	7.06e-05	0.00166	CbGpPWpGaD
Modafinil—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	7.05e-05	0.00166	CbGpPWpGaD
Modafinil—CYP2B6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.02e-05	0.00165	CbGpPWpGaD
Modafinil—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.97e-05	0.00164	CbGpPWpGaD
Modafinil—CYP2B6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.92e-05	0.00162	CbGpPWpGaD
Modafinil—ADRA1B—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	6.9e-05	0.00162	CbGpPWpGaD
Modafinil—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.89e-05	0.00162	CbGpPWpGaD
Modafinil—CYP3A5—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.86e-05	0.00161	CbGpPWpGaD
Modafinil—ADRA1B—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	6.82e-05	0.0016	CbGpPWpGaD
Modafinil—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	6.8e-05	0.000369	CcSEcCtD
Modafinil—Dizziness—Prednisolone—chronic obstructive pulmonary disease	6.79e-05	0.000369	CcSEcCtD
Modafinil—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	6.78e-05	0.00159	CbGpPWpGaD
Modafinil—CYP3A5—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.76e-05	0.00159	CbGpPWpGaD
Modafinil—Insomnia—Prednisone—chronic obstructive pulmonary disease	6.75e-05	0.000366	CcSEcCtD
Modafinil—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	6.7e-05	0.000364	CcSEcCtD
Modafinil—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	6.57e-05	0.000356	CcSEcCtD
Modafinil—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	6.49e-05	0.000352	CcSEcCtD
Modafinil—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	6.49e-05	0.00152	CbGpPWpGaD
Modafinil—Rash—Prednisolone—chronic obstructive pulmonary disease	6.48e-05	0.000351	CcSEcCtD
Modafinil—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	6.47e-05	0.000351	CcSEcCtD
Modafinil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	6.45e-05	0.00151	CbGpPWpGaD
Modafinil—CYP2B6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.45e-05	0.00151	CbGpPWpGaD
Modafinil—Fatigue—Prednisone—chronic obstructive pulmonary disease	6.44e-05	0.000349	CcSEcCtD
Modafinil—Headache—Prednisolone—chronic obstructive pulmonary disease	6.44e-05	0.000349	CcSEcCtD
Modafinil—Constipation—Prednisone—chronic obstructive pulmonary disease	6.39e-05	0.000346	CcSEcCtD
Modafinil—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	6.37e-05	0.00149	CbGpPWpGaD
Modafinil—CYP2B6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.36e-05	0.00149	CbGpPWpGaD
Modafinil—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.36e-05	0.00149	CbGpPWpGaD
Modafinil—CYP3A5—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.3e-05	0.00148	CbGpPWpGaD
Modafinil—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.27e-05	0.00147	CbGpPWpGaD
Modafinil—CYP3A5—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.22e-05	0.00146	CbGpPWpGaD
Modafinil—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	6.17e-05	0.00145	CbGpPWpGaD
Modafinil—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	6.15e-05	0.000334	CcSEcCtD
Modafinil—CYP2B6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.11e-05	0.00144	CbGpPWpGaD
Modafinil—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	6.11e-05	0.000331	CcSEcCtD
Modafinil—Nausea—Prednisolone—chronic obstructive pulmonary disease	6.1e-05	0.000331	CcSEcCtD
Modafinil—CYP2B6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.03e-05	0.00142	CbGpPWpGaD
Modafinil—CYP3A5—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.97e-05	0.0014	CbGpPWpGaD
Modafinil—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.96e-05	0.0014	CbGpPWpGaD
Modafinil—Urticaria—Prednisone—chronic obstructive pulmonary disease	5.93e-05	0.000322	CcSEcCtD
Modafinil—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	5.9e-05	0.00032	CcSEcCtD
Modafinil—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	5.9e-05	0.00032	CcSEcCtD
Modafinil—CYP3A5—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.89e-05	0.00138	CbGpPWpGaD
Modafinil—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.89e-05	0.00138	CbGpPWpGaD
Modafinil—ADRA1B—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	5.84e-05	0.00137	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	5.81e-05	0.00136	CbGpPWpGaD
Modafinil—ADRA1B—AMPK Signaling—TP53—chronic obstructive pulmonary disease	5.81e-05	0.00136	CbGpPWpGaD
Modafinil—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.8e-05	0.00136	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	5.72e-05	0.00134	CbGpPWpGaD
Modafinil—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.72e-05	0.00134	CbGpPWpGaD
Modafinil—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	5.5e-05	0.000298	CcSEcCtD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	5.38e-05	0.00126	CbGpPWpGaD
Modafinil—Asthenia—Prednisone—chronic obstructive pulmonary disease	5.36e-05	0.000291	CcSEcCtD
Modafinil—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	5.33e-05	0.00125	CbGpPWpGaD
Modafinil—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.3e-05	0.00124	CbGpPWpGaD
Modafinil—Pruritus—Prednisone—chronic obstructive pulmonary disease	5.28e-05	0.000287	CcSEcCtD
Modafinil—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.23e-05	0.00123	CbGpPWpGaD
Modafinil—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	5.23e-05	0.00123	CbGpPWpGaD
Modafinil—ADRA1B—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	5.22e-05	0.00123	CbGpPWpGaD
Modafinil—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	5.11e-05	0.000277	CcSEcCtD
Modafinil—ADRA1B—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	4.97e-05	0.00117	CbGpPWpGaD
Modafinil—Dizziness—Prednisone—chronic obstructive pulmonary disease	4.94e-05	0.000268	CcSEcCtD
Modafinil—CYP2B6—Metabolism—APIP—chronic obstructive pulmonary disease	4.92e-05	0.00115	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.9e-05	0.00115	CbGpPWpGaD
Modafinil—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.87e-05	0.00114	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	4.84e-05	0.00114	CbGpPWpGaD
Modafinil—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.83e-05	0.00114	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—APIP—chronic obstructive pulmonary disease	4.81e-05	0.00113	CbGpPWpGaD
Modafinil—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.81e-05	0.00113	CbGpPWpGaD
Modafinil—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.77e-05	0.00112	CbGpPWpGaD
Modafinil—Vomiting—Prednisone—chronic obstructive pulmonary disease	4.75e-05	0.000257	CcSEcCtD
Modafinil—Rash—Prednisone—chronic obstructive pulmonary disease	4.71e-05	0.000255	CcSEcCtD
Modafinil—Dermatitis—Prednisone—chronic obstructive pulmonary disease	4.7e-05	0.000255	CcSEcCtD
Modafinil—Headache—Prednisone—chronic obstructive pulmonary disease	4.68e-05	0.000254	CcSEcCtD
Modafinil—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.62e-05	0.00108	CbGpPWpGaD
Modafinil—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	4.6e-05	0.00108	CbGpPWpGaD
Modafinil—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	4.57e-05	0.00107	CbGpPWpGaD
Modafinil—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.56e-05	0.00107	CbGpPWpGaD
Modafinil—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4.55e-05	0.00107	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	4.52e-05	0.00106	CbGpPWpGaD
Modafinil—ADRA1B—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	4.45e-05	0.00104	CbGpPWpGaD
Modafinil—SLC6A3—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	4.45e-05	0.00104	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	4.44e-05	0.00104	CbGpPWpGaD
Modafinil—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.44e-05	0.00104	CbGpPWpGaD
Modafinil—Nausea—Prednisone—chronic obstructive pulmonary disease	4.44e-05	0.000241	CcSEcCtD
Modafinil—SLC6A3—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	4.43e-05	0.00104	CbGpPWpGaD
Modafinil—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.38e-05	0.00103	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	4.36e-05	0.00102	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	4.36e-05	0.00102	CbGpPWpGaD
Modafinil—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.21e-05	0.000989	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.19e-05	0.000984	CbGpPWpGaD
Modafinil—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.15e-05	0.000975	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	4.15e-05	0.000974	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	4.15e-05	0.000974	CbGpPWpGaD
Modafinil—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.13e-05	0.00097	CbGpPWpGaD
Modafinil—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.07e-05	0.000957	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	4.01e-05	0.000941	CbGpPWpGaD
Modafinil—ADRA1B—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	3.98e-05	0.000934	CbGpPWpGaD
Modafinil—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.82e-05	0.000898	CbGpPWpGaD
Modafinil—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.8e-05	0.000891	CbGpPWpGaD
Modafinil—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.77e-05	0.000885	CbGpPWpGaD
Modafinil—SLC6A3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.75e-05	0.00088	CbGpPWpGaD
Modafinil—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.74e-05	0.000879	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	3.72e-05	0.000872	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	3.64e-05	0.000855	CbGpPWpGaD
Modafinil—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.6e-05	0.000845	CbGpPWpGaD
Modafinil—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.55e-05	0.000833	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	3.52e-05	0.000826	CbGpPWpGaD
Modafinil—ADRA1B—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	3.48e-05	0.000817	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	3.39e-05	0.000796	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.26e-05	0.000765	CbGpPWpGaD
Modafinil—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.19e-05	0.000749	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.18e-05	0.000748	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—GC—chronic obstructive pulmonary disease	3.17e-05	0.000744	CbGpPWpGaD
Modafinil—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.14e-05	0.000738	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	3.1e-05	0.000727	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.95e-05	0.000692	CbGpPWpGaD
Modafinil—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.93e-05	0.000688	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	2.9e-05	0.00068	CbGpPWpGaD
Modafinil—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.89e-05	0.000678	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.88e-05	0.000676	CbGpPWpGaD
Modafinil—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	2.82e-05	0.000663	CbGpPWpGaD
Modafinil—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	2.79e-05	0.000654	CbGpPWpGaD
Modafinil—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.78e-05	0.000652	CbGpPWpGaD
Modafinil—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.74e-05	0.000643	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.67e-05	0.000626	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.65e-05	0.000622	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	2.51e-05	0.00059	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.46e-05	0.000578	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.44e-05	0.000573	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.42e-05	0.000567	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	2.39e-05	0.000562	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.28e-05	0.000536	CbGpPWpGaD
Modafinil—SLC6A3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.25e-05	0.000528	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.25e-05	0.000528	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.24e-05	0.000527	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.23e-05	0.000525	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.23e-05	0.000523	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.23e-05	0.000523	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	2.18e-05	0.000513	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.15e-05	0.000505	CbGpPWpGaD
Modafinil—ADRA1B—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.15e-05	0.000505	CbGpPWpGaD
Modafinil—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	2.14e-05	0.000503	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.06e-05	0.000485	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.04e-05	0.000479	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.03e-05	0.000477	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.97e-05	0.000462	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.92e-05	0.00045	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.87e-05	0.000438	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.79e-05	0.000419	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.77e-05	0.000416	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.73e-05	0.000407	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.73e-05	0.000406	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.71e-05	0.000402	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.69e-05	0.000397	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	1.67e-05	0.000393	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.62e-05	0.00038	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.57e-05	0.000369	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.56e-05	0.000367	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	1.53e-05	0.000358	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.48e-05	0.000348	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.46e-05	0.000343	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.44e-05	0.000338	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.44e-05	0.000338	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.41e-05	0.00033	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.38e-05	0.000324	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.35e-05	0.000317	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.34e-05	0.000314	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.31e-05	0.000307	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	1.29e-05	0.000304	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.21e-05	0.000285	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.21e-05	0.000283	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.21e-05	0.000283	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.2e-05	0.000282	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.19e-05	0.00028	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.18e-05	0.000278	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	1.18e-05	0.000277	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	1.18e-05	0.000277	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.17e-05	0.000275	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.16e-05	0.000272	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.1e-05	0.000259	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.1e-05	0.000259	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.1e-05	0.000258	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.1e-05	0.000257	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.09e-05	0.000255	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.08e-05	0.000253	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	1.08e-05	0.000253	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.05e-05	0.000248	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.05e-05	0.000245	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.02e-05	0.00024	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.02e-05	0.000239	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.01e-05	0.000237	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.91e-06	0.000233	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	9.8e-06	0.00023	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	9.39e-06	0.000221	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	9.19e-06	0.000216	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.07e-06	0.000213	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.94e-06	0.00021	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.33e-06	0.000196	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.27e-06	0.000194	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.15e-06	0.000191	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	8.06e-06	0.000189	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.9e-06	0.000185	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.87e-06	0.000185	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	7.78e-06	0.000183	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.69e-06	0.000181	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.6e-06	0.000178	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.35e-06	0.000172	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.2e-06	0.000169	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	7.11e-06	0.000167	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	7.1e-06	0.000167	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.07e-06	0.000166	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.97e-06	0.000164	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	6.95e-06	0.000163	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	6.8e-06	0.00016	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	6.64e-06	0.000156	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.54e-06	0.000153	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.52e-06	0.000153	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.49e-06	0.000152	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.2e-06	0.000145	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.15e-06	0.000145	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.89e-06	0.000138	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.45e-06	0.000128	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.38e-06	0.000126	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	5.37e-06	0.000126	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.29e-06	0.000124	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	5.14e-06	0.000121	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.01e-06	0.000118	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	4.9e-06	0.000115	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.86e-06	0.000114	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.76e-06	0.000112	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.75e-06	0.000112	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	4.68e-06	0.00011	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	4.18e-06	9.82e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	4e-06	9.4e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4e-06	9.39e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.66e-06	8.59e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	3.23e-06	7.58e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	3.09e-06	7.25e-05	CbGpPWpGaD
